Is Emerson Electric (EMR) a risky stock?
As of July 21, 2026, Clavix grades Emerson Electric (EMR) C+ for risk, a composite score of 66 out of 100 on an A+ to F scale, which puts EMR in the "solid" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind EMR's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how EMR scores on each, as of July 21, 2026.
What's moving EMR's risk right now
Company-specific signals Clavix flags behind EMR's current grade, drawn from recent news and filings as of July 21, 2026.
The university had claimed it needed the 124-year-old home's lot to make room for its new medical school headquarters.
This enhancement strengthens Amazon EMR's competitive positioning in the big data and Spark analytics market, potentially making AWS more attractive for cost-sensitive, large-scal…
What a C+ grade means
On the Clavix A+ to F scale, EMR's composite of 66 falls in the B band (65–79), read as "solid." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell EMR or any security. Grades are risk indicators, not predictions of return. Data may be delayed.